
Satellite Symposium
Saturday, May 4th, 2024 • 6:30pm - 8:30pm • Delta Hotels by Marriott Toronto: Soco Ballroom C
Overview
Explore the clinical benefits and economic advantages of exclusive human milk-based nutrition in mitigating morbidities among preterm infants. Engage with leading experts as we discuss practical, cost effective strategies for implementing these protocols in neonatal care settings.
Learning Objectives
-
Demonstrate the cost-effectiveness of implementing exclusive human milk-based nutrition protocols in neonatal intensive care units (NICUs) to reduce morbidities associated with preterm birth.
- Educate healthcare professionals and stakeholders about the clinical benefits of exclusive human milk-based nutrition for critically ill, preterm infants.
- Interpret exclusive human milk-based nutrition strategies as a standard of care to enhance health outcomes and mitigate long-term healthcare costs for preterm infants.


Jonathan Swanson, MD, MSc, FAAP
Professor of Pediatrics, Chief Quality Officer for Children’s Services and Medical Director for the Neonatal Intensive Care Unit (NICU) University of Virginia Children’s Hospital in Charlottesville, VA

Jenelle Ferry, MD
Neonatologist, Director of Feeding, Nutrition, and Infant Development Pediatrix Medical Group of Florida and St. Joseph’s Women’s Hospital

Erin Hamilton Spence, MD, IBCLC, FAAP, FABM
Director, Clinical Education and Professional Development Prolacta Bioscience